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Lung volumes identify an at-risk group 
in persons with prolonged secondhand 
tobacco smoke exposure but without 
overt airflow obstruction
Mehrdad Arjomandi,1,2,3 Siyang Zeng,1,3 Jeroen Geerts,4 Rachel K Stiner,1,3 
Bruce Bos,4 Ian van Koeverden,4 Jason Keene,5 Brett Elicker,6,7 Paul D Blanc,1,3,2,6 
Warren M Gold1,6
Chronic obstructive pulmonary disease
AbstrAct
Introduction Exposure to secondhand smoke (SHS) is 
associated with occult obstructive lung disease as evident 
by abnormal airflow indices representing small airway 
disease despite having preserved spirometry (normal 
forced expiratory volume in 1 s-to-forced vital capacity 
ratio, FEV1/FVC). The significance of lung volumes that 
reflect air trapping in the presence of preserved spirometry 
is unclear.
Methods To investigate whether lung volumes 
representing air trapping could determine susceptibility 
to respiratory morbidity in people with SHS exposure but 
without spirometric chronic obstructive pulmonary disease, 
we examined a cohort of 256 subjects with prolonged 
occupational SHS exposure and preserved spirometry. We 
elicited symptom prevalence by structured questionnaires, 
examined functional capacity (maximum oxygen uptake, 
VO2max) by exercise testing, and estimated associations 
of those outcomes with air trapping (plethysmography-
measured residual volume-to-total lung capacity ratio, 
RV/TLC), and progressive air trapping with exertion 
(increase in fraction of tidal breathing that is flow limited 
on expiration during exercise (per cent of expiratory flow 
limitation, %EFL)).
results RV/TLC was within the predicted normal limits, 
but was highly variable spanning 22%±13% and 16%±8% 
across the increments of FEV1/FVC and FEV1, respectively. 
Respiratory complaints were prevalent (50.4%) with the 
most common symptom being ≥2 episodes of cough per 
year (44.5%). Higher RV/TLC was associated with higher 
OR of reporting respiratory symptoms (n=256; r2=0.03; 
p=0.011) and lower VO2max (n=179; r
2=0.47; p=0.013), 
and %EFL was negatively associated with VO2max (n=32; 
r2=0.40; p=0.017).
conclusions In those at risk for obstruction due to SHS 
exposure but with preserved spirometry, higher RV/TLC 
identifies a subgroup with increased respiratory symptoms 
and lower exercise capacity.
IntroductIon
The forced expiratory volume in 1 s (FEV1), 
forced vital capacity (FVC) and their ratio 
(FEV1/FVC) commonly define airflow obstruc-
tion.1 2 The widely used Global Initiative for 
Obstructive Lung Disease (GOLD) criteria 
require an absolute reduction in FEV1/
FVC below 0.70 (stage 1), with higher stages 
of chronic obstructive pulmonary disease 
(COPD) defined by a concomitant reduc-
tion in FEV1 as a per cent predicted.
3 There 
has been far less attention given to the diag-
nostic implications of other lung function 
abnormalities that could be markers of subtle 
airway disease in the absence of overt COPD.
Air trapping, defined as abnormal increase 
in volume of air remaining in the lungs 
at the end of spontaneous exhalation, is a 
manifestation of obstructive lung diseases.3–6 
Although usually thought of as a consequence 
of airflow obstruction, air trapping can persist 
even after airflow obstruction (measured by 
FEV1 and FEV1/FVC) has improved, and 
thus may reflect additional pathophysiology 
beyond what is measured by these spiro-
metric measures of airflow obstruction.7–9 
Previous studies have documented that, in 
those with overt chronic airflow obstruction 
(abnormal FEV1/FVC), air trapping is asso-
ciated with dyspnoea, exercise limitation 
Key messages
 ► In this study of a cohort at risk for chronic 
obstructive pulmonary disease (COPD) due to 
prolonged (although remote) exposure to second-
hand tobacco smoke but with normal spirometry, 
we found that lung volumes that represent air 
trapping, even when within the normal range, were 
associated with higher occurrence of respiratory 
symptoms and lower exercise capacity.
 ► Our findings show that lung volume measurements 
provide an additional dimension to spirometry for 
characterisation and prognostication of obstructive 
lung disease in these individuals without overt 
COPD.
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and mortality.10–14 Others have shown that in smokers 
without GOLD-defined COPD, evaluation of air trapping 
and hyperinflation indices, beyond the commonly used 
spirometric indices, could avoid underestimation of clin-
ically important physiologic impairment.15 16 Despite this, 
air trapping as measured by lung volumes often is not 
emphasised in the interpretation of lung function when 
spirometry findings are otherwise within normal limits.
In previous studies of never-smoking flight attendants 
with history of prolonged occupational exposure to 
secondhand tobacco smoke (SHS) in aircraft cabin, we 
found the exposed flight attendants to have decreased 
flow at low-lung and mid-lung volumes (forced expi-
ratory flows at 25%–75% and at 75% of FVC (FEF25–75 
and FEF75)) while having preserved spirometry (normal 
FEV1/FVC) and thus not meeting the spirometric criteria 
for COPD.17 18 In this study, we wished to examine the 
clinical significance of lung volumes representing air 
trapping as measured by the ratio of residual volume to 
total lung capacity (RV/TLC) in the same cohort. We 
hypothesised that in individuals at risk for COPD due to 
exposure to SHS but with preserved spirometry (normal 
FEV1/FVC and FEV1 by lower limit of normal (LLN) crite-
rion), lung volumes reflecting air trapping (RV/TLC) 
define a phenotype with greater respiratory symptoms 
and lower exercise capacity. We further hypothesised that 
radiographic measurement of lung density attenuation 
consistent with radiographic ‘gas trapping’ will also be 
predictive of those outcomes.
Methods
study overview
This was an observational, cross-sectional analysis of find-
ings in a larger cohort of subjects with a range of SHS 
exposure.17 18 We used data from this cohort to examine 
the associations among airflow obstruction indices 
(FEV1/FVC, FEV1, FEF25–75 and FEF75), air trapping (RV/
TLC and radiographic gas trapping), progressive air trap-
ping (defined as an increase in either fraction of tidal 
volume (VT) that is flow limited on expiration (per cent 
of expiratory flow limitation, %EFL) or end-expiratory 
lung volume (EELV or functional residual capacity, 
FRC) during exercise), respiratory symptoms and exer-
cise capacity (maximum oxygen uptake (VO2max) and 
maximum work achieved (Wattsmax)).
study population
Between July 2007 and July 2015, we recruited US airline 
flight crewmembers as part of an investigation of the 
potential adverse health effects of the cabin environment 
on those employed before and after introduction of the 
ban on smoking in US commercial aircraft. Crewmem-
bers were eligible to participate in the study if they had 
worked ≥5 years in aircraft. A referent group of ‘sea-level’ 
subjects who lived in San Francisco Bay area and had 
never been employed as airline crewmembers were also 
recruited. All subjects were non-smokers defined by 
never smoking or, in ever smokers, no smoking for ≥20 
years and a cumulative history of smoking <20 pack-
years. Overall, 440 subjects were enrolled in the larger 
cohort, of whom 49 did not undergo plethysmography 
and were not eligible for the current analysis. Other-
wise eligible subjects were excluded if they manifested 
impaired spirometry (abnormal FEV1/FVC or FEV1 
by LLN) (n=61), body mass index ≥30 kg/m2 (n=21), 
had no SHS exposure (n=26), or reported any known 
medical diagnosis that could have adversely affected 
their lung function (n=27). Overall, 256 eligible subjects 
with preserved spirometry were included in the study. 
Of those, 179 agreed and underwent cardiopulmonary 
exercise testing (figure 1). To examine the effect of air 
trapping during exercise, starting July 2013, subjects were 
offered an additional exercise protocol of inspiratory 
capacity (IC) and maximal expiratory flow (MEF) meas-
urements at progressive levels of exercise for determina-
tion of %EFL and EELV (n=32). Additionally, to demon-
strate radiographic ‘gas trapping’, subjects were offered 
and 23 agreed to undergo thoracic CT imaging using a 
low radiation protocol. Characteristics of the subgroups 
undergoing IC with MEF measurements and CT imaging 
are shown in online supplementary e-Table 1. Written 
institutional review board-approved informed consent 
was obtained from all participants.
shs exposure characterisation
SHS exposure was characterised by a questionnaire 
developed by UCSF Flight Attendant Medical Research 
Institute (FAMRI) Center of Excellence,19 and modified 
to acquire information on airline-related occupational 
history, as described previously.17 18 Briefly, this included 
employer airlines, duration of employment and flight 
routes with quantification of ‘cabin SHS exposure’ as the 
number of years during which the crewmembers were 
exposed to SHS in aircraft. Other possible sources of 
SHS exposure were also explored by questioning subjects 
about their non-cabin exposures in additional settings, as 
described previously.20
Pulmonary function and cardiopulmonary exercise testing
Lung function measurement procedures are detailed in 
online supplementary e-Methods 1. Routine pulmonary 
function tests were performed in the seated position as 
described previously.17 Subjects performed symptom-lim-
ited, progressively increasing exercise tests in the supine 
position on a cycle ergometer as part of a separate study, 
which examined changes in diffusing capacity during 
exercise and required supine positioning.18 During this 
maximum VO2 testing, subjects were encouraged to 
continue exercise until a VO2 plateau effect on a breath-
to-breath analysis of oxygen consumption was visually 
observed. Additionally, a subset of subjects under-
went VT, IC and MEF measurements in seated position 
at increasing work rates corresponding to 20%, 40% 
and 80% of their VO2max as described previously.
21 22 The 
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volume of the VT that was flow limited on expiration (VFL) 
was measured on flow-volume loop graphics and used to 
calculate %EFL according to formula [(VFL/VT)*100] at 
each work rate. Similar methods were used to measure 
EELV (FRC) and RV (TLC-IC).
ct imaging of lungs
Two low-dose thoracic CT scans (at maximum inspi-
ration (TLC) and maximum expiration (RV)) were 
completed on a subset of participants (online supple-
mentary e-Methods 1). Lung density measurements 
were performed using ‘density mask’ technique23 by 
computing the per cent of voxels between −860 and −950 
Hounsfield unit (HU) on 1 mm sections at RV scans to 
determine low attenuation areas (mosaic perfusion) that 
reflects gas trapping (LAAexp −860 to −950) as described previ-
ously.24–28 Low attenuation lung density areas below −950 
HU on 1 mm sections at TLC scans (LAAinsp<−950) were also 
measured to examine presence of emphysema. A voxel 
threshold of ≥5% was used to define presence of gas trap-
ping or emphysema on respective measurements.
respiratory symptom scoring
Respiratory symptoms were assessed using modified 
Medical Research Council (mMRC) Dyspnea Scale and 
another self-reported internal questionnaire (FAMRI 
Center of Excellence questionnaire19) that elicited symp-
toms of dyspnoea, cough and subjects’ perception of a 
decreased level of exertion compared with peers over the 
year preceding enrolment. A dichotomous indicator of 
respiratory symptoms was defined by mMRC ≥1 or report 
of at least one respiratory symptom on the FAMRI ques-
tionnaire.
data analysis
We examined correlations among airflow indices and 
RV/TLC using the Pearson partial correlation test 
controlling for covariates. Linear or logistic regression 
analyses were used to examine the association among 
lung function (airflow indices or RV/TLC) or LAAexp −860 
to −950 as independent variables and respiratory symptoms 
or maximum observed work (VO2max and Wattsmax) as the 
440
328
49
281    - w Cabin SHS Exposure
47      - w/o Cabin SHS Exposure
Flight Crew
112 Sea-level Controls
Plethysmography Not Done
391 Subjects w Full PFTs
256 Subjects with Preserved Spirometry
179 Subjects with VO2Max Analysis
32 Subjects with EFL Analysis
23 Subjects with CT Imaging
135
61
21
27
26
Excluded from Analysis
Abnormal FEV1/FVC or FEV1
BMI ≥30 kg/m2
Known Pulmonary Disease
No Smoke Exposure
77 Did not participate in exercise
Total Subjects
Figure 1 Subject flow. BMI, body mass index; EFL, expiratory flow limitation; FEV1, forced expiratory volume in 1 s; FVC, 
forced vital capacity; PFT, pulmonary function test; SHS, secondhand tobacco smoke; VO2max, maximum oxygen uptake; w, 
with; w/o, without. 
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dependent variable. Models were adjusted for age, sex, 
height and weight unless noted otherwise.
Measurements of %EFL, VFL, RV and EELV at maximum 
exercise are technically challenging to perform. As an 
alternative, we assumed the rates of increase in these 
variables to provide a proxy for their values at maximum 
exercise. Thus, the rates of increase in %EFL, VFL, RV and 
EELV were estimated by linear regression approach, and 
then used as independent variables to determine their 
contribution to maximum exercise achieved.
To assess whether association between VO2max and RV/
TLC was mediated through airflow indices, we performed 
Sobel-Goodman mediation testing in ‘mediator models’29 
with VO2max (dependent variable), RV/TLC (indepen-
dent variable) and airflow indices (mediator variables), 
with inclusion of covariates (figure 2).
We performed receiver operating characteristic (ROC) 
analyses to examine the suitability of airflow indices 
(FEV1/FVC and FEV1) and air trapping (RV/TLC) as 
predictors of respiratory symptoms and exercise capacity 
(VO2max). For respiratory symptoms, a binary variable of 
having or not having any symptoms was used in ROC 
analysis. For exercise capacity, a binary variable of low 
and high capacity was generated based on the ability to 
achieve the predicted VO2max (≥100% predicted value) 
and used in ROC analysis. To obtain comparable area 
under the curve (AUC) values, the predictor variables 
were given a negative sign if they were inversely associ-
ated with the outcome variable (eg, the value of RV/TLC 
was made negative for its contribution to VO2max). The 
AUC values from RV/TLC, FEV1/FVC, FEV1 and FRC 
(per cent-predicted values) were calculated with adjust-
ment for covariates, and compared for their ability to 
discriminate between the binary outcomes. To construct 
risk groups, optimal cut-points of RV/TLC for each ROC 
analysis were calculated, and used to define at-risk and 
not at-risk groups.
Sensitivity analyses on effects from smoking or exceeding 
abnormal predicted limits for RV, TLC, FVC or FRC were 
done and results were congruent to primary results.
results
rV/tlc had a wide variance and was not correlated with 
FeV1/FVc in subjects with preserved spirometry
Subject characteristics for the 256 participants included 
in the analysis are shown in table 1. The subjects were 
predominantly women (232 (90.6%)) and never smokers 
(230 (89.8%)) and among those who had smoked, the 
median (IQR) amount of smoking was 4.0 (3.0–13.8) 
pack-years. All subjects had past exposure to SHS. The 
prevalence of exposure to cabin and non-cabin SHS 
was 62.9% and 93.3%, respectively. One subject had 
FVC below LLN, and four had TLC below LLN (online 
supplementary e-Table 2). The subgroup of subjects who 
underwent exercise testing (n=179) was slightly younger 
with less average SHS exposure and otherwise was similar 
in characteristics (table 1).
FEV1/FVC was inversely correlated with RV/TLC 
(correlation coefficient (r)=−0.34; p<0.001); however, 
this correlation was no longer present after controlling 
for age, height, weight and sex (partial correlation coef-
ficient (rp)=−0.01; p=0.896) (online supplementary 
e-Table 3). Additionally, the inverse correlation between 
FEV1 and RV/TLC was moderate when adjusted for 
covariates (rp=−0.37; p<0.001) (online supplementary 
e-Table 3). Consistently, the RV/TLC, although within 
the predicted normal limits, manifested a wide range of 
observed values with an average span of 22.4%±13.1% 
and 16.0%±7.9% across the increments of FEV1/FVC 
and FEV1, respectively, corresponding to coefficient of 
variation (SD-to-mean ratio) ranges of 13.6%–27.8% and 
11.1%–32.9% (figure 3).
higher rV/tlc was associated with having respiratory 
symptoms in subjects with preserved spirometry
Respiratory complaints defined by mMRC were present 
in 9.0% of subjects (table 1). Using an internal respira-
tory questionnaire that included measurement of cough, 
respiratory symptoms were present in half the group 
(50.4%) with the most common symptom being ≥2 
episodes of cough per year (44.5%) (table 1). In adjusted 
models, higher RV/TLC was non-significantly associated 
with an mMRC score ≥1 (p=0.112). Using our internal 
questionnaire, higher RV/TLC was significantly associ-
ated with the likelihood of having any of the respiratory 
symptoms with an average of 9% increase in OR for each 
1% increase in RV/TLC (p=0.011) (table 2). In adjusted 
models, FEV1/FVC was also associated with respiratory 
symptoms; however, the direction of the association 
was opposite to that anticipated for obstructive lung 
disease (table 2). Inclusion of FEV1/FVC as a covariate 
in the same model as RV/TLC did not affect its associ-
ation with respiratory symptoms. Other airflow indices 
were not associated with having respiratory symptoms 
(table 2) nor did they affect the association of RV/TLC 
with respiratory symptoms when they were individually 
included in a multivariable lung function model along 
with RV/TLC.
Airflow Obstruction
(FEV1/FVC & FEV1)
Air Trapping
(RV/TLC)
Indirect Effect
(Airflow-mediated)
Direct Effect
Maximum
Exercise
Capacity
Figure 2 Mediation effect modelling diagram. Association 
of air trapping with maximum exercise capacity may be 
mediated through its effect on airflow indices. FEV1, forced 
expiratory volume in 1 s; FVC, forced vital capacity; RV, 
residual volume; TLC, total lung capacity.
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On ROC analysis, RV/TLC was a better, although not 
statistically significantly different, predictor than FEV1 
and FEV1/FVC to discriminate between the subjects with 
and without reports of respiratory symptoms. The AUC 
measurements for RV/TLC were 0.59 while those for FEV1 
and FEV1/FVC were 0.54 and 0.44, respectively. To identify 
at-risk groups, subjects were categorised based on having 
an RV/TLC per cent-predicted value of 90% (statistical 
optimised cut-point for ROC analysis was 89% predicted). 
Subjects with RV/TLC values ≥90% predicted were 92% 
more likely to report respiratory symptoms (p=0.015).
higher rV/tlc was associated with lower maximum exercise 
capacity in subjects with preserved spirometry
In the subgroup that underwent exercise testing 
(n=179), the average VO2max was 1.496±0.429 L/min 
(99.6%±23.5% predicted) with a range of 0.695–3.004 L/
min reflecting 53%–186% of normal values based on 
Wasserman predicted formulas30 (table 3). In adjusted 
models, RV/TLC was inversely associated with maximum 
work level achieved (both VO2max and Wattsmax) (table 4 
and online supplementary e-Table 4). On average, there 
was a decrease of 16±6 mL/min in VO2max and 1.4±0.6 W 
Table 1 Subjects’ characteristics
Characteristics
Subjects with preserved 
spirometry (n=256)
Subgroup that performed 
exercise (n=179)
Age (years) 56.1±11.0 54.7±11.3
Female sex, n (%) 232 (90.6) 163 (91.1)
BMI (kg/m2) 23.5±2.9 23.5±3.0
FEV1 (% predicted) 103±12 103±12
FVC (% predicted) 106±12 106±12
FEV1/FVC (%) 77±4 77±4
FEV1/FVC (% predicted) 98±5 98±4
FEF25–75 (% predicted) 92±23 91±21
FEF75 (% predicted) 41±16 43±17
TLC (% predicted) 101±10 101±10
RV (% predicted) 93±15 92±16
(RV/TLC) (%) 34±6 34±6
(RV/TLC) (% predicted) 92±12 92±12
FRC (% predicted) 96±18 97±18
DcoSB adjusted for Hgb (% predicted) 79±10 79±10
mMRC Dyspnea Scale ≥1, n (%) 23 (9.0) 15 (8.4)
Symptoms
  Subjects ever experiencing shortness of breath, n (%) 36 (14.1) 23 (12.8)
  Subjects with cough ≥2 episodes/year, n (%) 114 (44.5) 73 (40.8)
  Subjects with less activity than peers, n (%) 10 (3.9) 5 (2.8)
  Subjects with any respiratory symptoms, n (%) 129 (50.4) 83 (46.4)
SHS exposure
  Ever cabin SHS exposure, n (%) 161 (62.9) 102 (57.0)
   Cabin SHS exposure (years) 12.1±11.7 10.1±10.7
   Any form of non-cabin SHS exposure, n/N (%) 196/210 (93.3) 130/139 (93.5)
   Childhood home SHS exposure, n/N (%) 133/207 (64.3) 87/138 (63.0)
   Adult home SHS exposure, n/N (%) 80/207 (38.6) 48/138 (34.8)
   Non-airline occupational SHS exposure, n/N (%) 73/198 (36.9) 53/136 (38.9)
   Other SHS exposure, n/N (%) 133/193 (68.9) 90/130 (69.2)
Demographics, lung function and secondhand smoke (SHS) exposure status in subjects with preserved spirometry and the subgroup that 
underwent exercise testing. Other SHS exposure was defined as non-aircraft cabin SHS exposure outside the work or home environment 
such as in recreational public places. Data are presented as mean±SD or number of subjects with positive value for the variable (n) out of the 
total number of subjects (N) and percentage of subjects (%).
BMI, body mass index; DcoSB, single-breath diffusing capacity of carbon monoxide; FEF25–75, maximum airflow at mid-lung volume; FEF75, 
maximum airflow at low-lung volume; FEV1, forced expiratory volume in 1 s; FRC, functional residual capacity; FVC, forced vital capacity; 
Hgb, haemoglobin; mMRC, modified Medical Research Council; RV, residual volume; TLC, total lung capacity.
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in Wattsmax with each 1% increase in RV/TLC (r
2=0.47, 
p=0.013 and r2=0.47, p=0.023, respectively).
In adjusted models that included only a single lung 
function variable, none (FEV1/FVC, FEV1, FEF25−75 or 
FEF75) was associated with VO2max (table 4). Further-
more, when FEV1/FVC, FEV1, FEF25–75 or FEF75 each was 
individually included in multivariable lung function 
models along with RV/TLC, RV/TLC retained its statis-
tical significance (models’ r2 ≥0.47; models’ p≤0.044) 
(online supplementary e-Figure 1). The association of 
these airflow indices with Wattsmax followed a similar 
pattern. Additionally, when tested for any potential 
confounding effects of airflow indices, FEV1/FVC, FEV1, 
FEF25–75 or FEF75 had no clinically or statistically signifi-
cant mediation effect on the association between RV/
TLC and VO2max (figure 2; table 5).
On ROC analysis, RV/TLC was a better, although not 
statistically significantly different, predictor than FEV1 and 
FEV1/FVC to discriminate between the subjects who were 
and those who were not able to achieve their 100% predicted 
maximum exercise capacity (100% predicted VO2max). The 
AUC measurement for RV/TLC was 0.60 while those for 
FEV1 and FEV1/FVC were 0.55 and 0.46 (figure 4). Subjects 
with RV/TLC values ≥90% predicted were 49% less likely to 
achieve their predicted maximum exercise capacity (VO2max 
of 100% predicted or higher) (p=0.045).
Progressive eFl during exercise was associated with lower 
maximum exercise capacity in subjects with preserved 
spirometry
In the subgroup that underwent IC and MEF measure-
ments (n=32), 9 had EFL at baseline, 25 developed EFL 
with exercise and 21 had progressive EFL (increasing 
%EFL) during exercise (online supplementary e-Table 
5). The rate of change in %EFL was inversely associated 
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Figure 3 Association between RV/TLC and FEV1/FVC or FEV1. Box plots show distributions of RV/TLC versus FEV1/FVC (A) 
or FEV1 (B) by 5% increments. Values are shown as per cent predicted of normal. FEV1, forced expiratory volume in 1 s; FVC, 
forced vital capacity; RV, residual volume; TLC, total lung capacity. 
Table 2 Association of subjects’ symptoms with lung function
Variable
Having any respiratory symptoms Having mMRC score ≥1
r2 OR±SEM P values r2 OR±SEM P values
RV/TLC (%) 0.03 1.09±0.04 0.011 0.05 1.09±0.06 0.112
FEV1/FVC (%) 0.03 1.07±0.04 0.045 0.03 1.01±0.06 0.882
FEV1 (L) 0.02 0.58±0.25 0.216 0.04 0.44±0.35 0.302
FEF25–75 (L/s) 0.02 1.10±0.24 0.681 0.03 1.06±0.40 0.875
FEF75 (L/s) 0.02 1.06±0.43 0.884 0.03 1.24±0.83 0.754
TLC (L) 0.02 0.72±0.19 0.204 0.03 0.84±0.38 0.698
RV (L) 0.02 1.59±0.72 0.310 0.03 1.72±1.30 0.471
FRC (L) 0.02 0.88±0.26 0.683 0.04 1.77±0.84 0.225
The subjects’ symptoms and activity level was scored as whether they have ever reported shortness of breath, cough ≥2 episodes/
year or less activity than peers. Logistic regression model of respiratory symptoms with lung functions and adjustments: OR of having 
symptoms=β0+β1(age)+β2(sex)+β3(height)+β4(weight)+β3(lung function index).
Significant P values are shown in bold. n=256.
 FEF25–75, maximum airflow at mid-lung volume; FEF75, maximum airflow at low-lung volume; FEV1, forced expiratory volume in 1 s; FRC, 
functional residual capacity; FVC, forced vital capacity; mMRC, modified Medical Research Council; r2, model fit; RV, residual volume; TLC, 
total lung capacity. 
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with maximum work level achieved (both VO2max and 
Wattsmax) (table 4 and online supplementary e-Table 4). 
On average, there was a decrease of 3.52±1.39 mL/min 
in VO2max and 0.42±0.14 W in Wattsmax with each 1%/W 
increase in slope of %EFL (r2=0.40, p=0.017 and r2=0.67, 
p=0.004, respectively). Similarly, the rate of change in 
VFL was inversely associated with maximum work level 
achieved (both VO2max and Wattsmax; r
2=0.42; p=0.009 and 
r2=0.64; p=0.021, respectively) (table 4 and online supple-
mentary e-Table 4). Pertinently, RV/TLC was associated 
with the rate of change in %EFL and VFL (0.5%±0.2%/W 
and 5.9±2.8 mL/W increase in %EFL and VFL per 10% 
increase in RV/TLC (online supplementary e-Table 6)). 
The rates of change in EELV (FRC) or RV were not asso-
ciated with maximum work achieved (table 4).
radiographic gas trapping was associated with lower 
maximum exercise capacity in subjects with preserved 
spirometry
In the subgroup that underwent CT imaging (n=23), the 
total lung voxels with low attenuation area (LAAexp −860 to −950) 
were 7.6%±13.5% with 9 out of 23 (39%) having ≥5% LAAexp 
−860 to −950. In adjusted models, LAAexp −860 to −950 was inversely 
associated with maximum work level achieved (both VO2max 
and Wattsmax) (table 4 and online supplementary e-Table 4). 
On average, there was a decrease of 9±4 mL/min in VO2max 
and 1.2±0.5 W in Wattsmax with each 1% increase in voxels 
representing gas trapping (r2=0.24; p=0.049 and r2=0.28; 
p=0.018, respectively). Furthermore, the association of 
LAAexp −860 to −950 with exercise capacity was not affected by 
inclusion of FEV1/FVC or FEF75 (model r
2 ≥0.24; p≤0.048) 
and minimally affected by inclusion of FEV1 or FEF25–75 
(model r2 ≥0.20; p≤0.077). Only 2 out of the 23 subjects that 
underwent CT imaging had ≥5% LAAinsp<−950 meeting the 
criteria for presence of emphysema.
higher exposure to shs was associated with lower maximum 
exercise capacity
Complete non-cabin SHS exposure data were available in 
127 out of the 179 subjects who underwent maximum effort 
exercise testing. In these, length of exposure to cabin SHS 
was inversely associated with maximum work level achieved 
(both VO2max and Wattsmax) (table 6 and online supplemen-
tary e-Table 7). On average, there was a decrease of 7±4 mL/
min in VO2max and 0.8±0.4 W in Wattsmax achieved with 
each year increase in exposure to cabin SHS (p=0.040 and 
p=0.027, respectively). Other measures of SHS exposure 
(SHS exposures from childhood, adult home and non-air-
line occupational) were not significantly associated with 
maximum exercise capacity (table 6 and online supplemen-
tary e-Table 7).
dIscussIon
In a cohort at risk for obstructive lung disease because 
of prolonged SHS exposure but with preserved spirom-
etry, we found RV/TLC to be overall within the predicted 
normal limits. However, RV/TLC showed remark-
able variability across the range of FEV1/FVC or FEV1, 
suggesting that, at least in this cohort with preserved 
spirometry, RV/TLC informs an additional dimension 
to the obstructive lung disease not captured by standard 
airflow indices. Higher RV/TLC was associated with 
greater odds of reporting respiratory symptoms, and 
was predictive of lower maximum exercise capacity, 
independent of the level of airflow indices (FEV1/FVC, 
FEV1, FEF25–75 or FEF75). In a subgroup of the subjects, we 
Table 3 Exercise parameters of subjects who performed 
exercise
Characteristics
Subgroup that 
performed 
exercise
VO2max (L/min) 1.496±0.429
VO2max (% predicted) 100±24
VO2max (mL/min·kg) 23.4±6.4
Wattsmax (W) 150.9±43.5
Wattsmax (% predicted) 134±33
VCO2max (L/min) 1.819±0.544
O2pulsemax (L/beat) 10.6±2.8
O2pulsemax (% predicted) 117±25
VEmax (L/min) 55.41±15.26
VEmax (% predicted) 113±26
RER 1.21±0.15
RRmax (breaths/min) 34.74±9.52
VTmax (L) 1.66±0.42
VTmax (% predicted) 84±16
VE/VO2max 37.4±6.4
VE/VCO2max 30.9±4.1
HRmax (beats/min) 142.1±18.7
Systolic BPbaseline (mm Hg) 121.7±16.9
Diastolic BPbaseline (mm Hg) 76.0±8.5
Systolic BPmax (mm Hg) 177.3±21.3
Diastolic BPmax (mm Hg) 92.5±9.9
VO2 at anaerobic threshold (L/min) 0.977±0.304
VE/VCO2 at anaerobic threshold 31.6±3.9
O2pulse at anaerobic threshold (L/beat) 8.7±2.6
Shortness of breath (Borg Scale) 4.1±1.9
Effort (Borg Scale) 5.1±1.9
Fatigue (Borg Scale) 4.5±1.9
Cardiopulmonary measurements in subjects who underwent 
exercise testing. Data are presented as mean±SD.
HRmax, maximum heart rate; O2pulsemax, oxygen uptake per 
heartbeat at maximum exercise; RER, respiratory exchange ratio 
(VCO2/ VO2) at maximum exercise; RRmax, maximum respiratory 
rate; VCO2max, maximum carbon dioxide production; VEmax, 
maximum minute ventilation value; VO2max, maximum oxygen 
uptake; VO2max·kg, maximum oxygen uptake per kilogram of body 
weight; VTmax, maximum tidal volume; Wattsmax, maximum work 
stage completed in watts.
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found many with normal RV/TLC to have EFL at rest, 
and many more to develop EFL with exercise. We also 
demonstrated that exercise capacity, although not asso-
ciated with an increase in EELV (FRC), was associated 
with progressive EFL (an increase in %EFL that in turn 
was related to RV/TLC), implicating higher RV/TLC as 
a possible mechanism that limits exercise capacity in this 
cohort with preserved spirometry. Finally, in a subgroup 
with imaging data, we found that LAAexp −860 to −950, the radi-
ographic estimation of air trapping, was also associated 
with lower maximum exercise capacity. Overall, our find-
ings show that in those at risk for obstruction due to SHS 
exposure but with preserved spirometry, the amount of 
air retained in lungs at the end of full expiration (RV/
TLC), even if within the predicted normal range, has 
prognostic value in estimating functional capacity.
Many studies have documented the significance of air 
trapping in patients with overt COPD and its association 
with increased morbidity and mortality.10–14 Others have 
shown that in mild disease or in smokers without GOLD-de-
fined COPD, air trapping and hyperinflation may be associ-
ated with physiologic impairment beyond the information 
provided by spirometry.15 16 Our study further uncovers the 
informative nature of lung volumes representing air trap-
ping, even when they are in normal range, in predicting 
respiratory symptoms and exercise capacity. In fact, we 
found that having RV/TLC of 90% predicted or higher 
doubled the likelihood of reporting respiratory symptoms 
and halved the likelihood of being able to achieve the 
expected normal exercise capacity. Although our study was 
done in a cohort of never smokers with prolonged SHS 
exposure, it is likely that its findings are generalisable to 
Table 4 Association of maximum exercise capacity with lung function
Predictor variable
Change in VO2max (mL/min)
r2 PE±SEM P values
RV/TLC (%) 0.47 −16±6 0.013
FEV1/FVC (%) 0.46 −12±7 0.070
FEV1 (L) 0.46 149±78 0.059
FEF25–75 (L/s) 0.45 −21±44 0.635
FEF75 (L/s) 0.46 −109±76 0.151
TLC (L) 0.47 113±47 0.017
RV (L) 0.45 −31±85 0.714
FRC (L) 0.47 −15±58 0.801
Slope of VFL (mL/W)* 0.42 −29±10 0.009
1% change in slope of %EFL (%/W)* 0.40 −3.52±1.39 0.017
Slope of EELV (FRC) (mL/W)* 0.27 16±18 0.390
Slope of RV (mL/W)* 0.26 −7±19 0.701
LAAexp −860 to −950† 0.24 −9±4 0.049
Association of maximum exercise capacity (VO2max) with lung function was estimated using the regression analyses with 
adjustment for age, sex, height and weight with inclusion of one lung function at a time based on the regression model: 
Work=β0+β1(age)+β2(sex)+β3(height)+β4(weight)+β5(lung function). n=179 unless otherwise noted. Significant p-values are shown in bold. 
*n=32.
†n=23. 
%EFL, per cent of expiratory flow limitation; EELV, end-expiratory lung volume; FEF25–75, maximum airflow at mid-lung volume; FEF75, 
maximum airflow at low-lung volume; FEV1, forced expiratory volume in 1 s; FRC, functional residual capacity; FVC, forced vital capacity; 
LAAexp −860 to −950, per cent low attenuation area between −860 and − 950 HU on RV scan representing radiographic gas trapping; PE±SEM, 
parameter estimate±SEM; r2, model fit; RV, residual volume; TLC, total lung capacity; VFL, volume of the tidal breath that is flow limited on 
expiration; VO2max, maximum oxygen uptake. 
Table 5 Test of possible mediation effect of airflow 
measures on association of maximum exercise capacity 
with air trapping
Mediating 
variable
Effect of RV/TLC on VO2max (mL/min)
Airflow-
mediated 
effect (%) P values
Non-
mediated 
effect (%) P values
FEV1/FVC 6.9 0.286 93.1 0.020
FEV1 15.2 0.237 84.8 0.042
FEF25–75 1.6 0.609 98.4 0.011
FEF75 2.0 0.655 98.0 0.014
To see if the association of hyperinflation (RV/TLC) with 
maximum exercise capacity (VO2max) was mediated through 
airflow indices, mediation analyses were performed with 
adjustment for age, sex, height, and weight and inclusion 
of one airflow index at a time based on the model: 
Work=β0+β1(age)+β2(sex)+β3(height)+β4(weight)+β5(RV/
TLC)+β6(airflow index). n=179. Significant p-values are shown in 
bold. 
FEF25–75, maximum airflow at mid-lung volume; FEF75, maximum 
airflow at low-lung volume; FEV1, forced expiratory volume in 1 s; 
FVC, forced vital capacity; RV, residual volume; TLC, total lung 
capacity; VO2max, maximum oxygen uptake. 
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others who are at risk for COPD due to any cause but have 
preserved spirometry. Furthermore, since many studies 
have reported worsened respiratory symptoms and exercise 
tolerance in patients with spirometric COPD and air trap-
ping,6 21 31 32 it would be interesting to ascertain whether 
RV/TLC is a uniform predictor of worse outcomes regard-
less of spirometry status of patients (preserved or spiromet-
rically defined COPD).
The physiologic mechanisms that result in air trapping 
have been extensively studied.33–35 In those with obstruc-
tion, active exhalation during exercise is thought to further 
augment air trapping via progressive increase in intratho-
racic pressure and thus earlier closure of small airways, a 
process that results in EFL and increased EELV, reduced 
vital capacity and exercise limitation. An intriguing finding 
in our study is that many subjects who did not have evidence 
of air trapping at baseline (by either RV/TLC or baseline 
EFL) proceeded to develop EFL with exertion. Similarly, in 
the small subgroup that underwent CT imaging, many had 
evidence of mosaic perfusion and gas trapping in the setting 
of normal RV/TLC. Overall, these observations underscore 
the value of physiologic measurements during exercise 
and radiographic CT imaging for diagnosis of subclinical 
obstructive lung disease. Furthermore, they convey the 
diverse underlying processes that are likely involved in 
development of air trapping, and the complexity in its defi-
nition through various testing modalities.
A recent study in heavy smokers with preserved spirometry 
showed evidence of dyspnoea and lower exercise tolerance 
associated with increased airway resistance and diaphragm 
dysfunction.36 However, that study did not evaluate the 
association of air trapping with such outcomes. Our study 
showed that, at least in this cohort with individuals at risk 
for obstruction but with preserved spirometry, the effect 
of lung volumes representing air trapping (RV/TLC) on 
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Figure 4 Receiver operating characteristic (ROC) analysis of lung function (FEV1/FVC, FEV1, FRC and RV/TLC) as predictors 
of maximum exercise capacity (VO2max). ROC curves were constructed by dichotomising having any respiratory symptoms (A) 
or reaching ≥100% predicted of maximum oxygen uptake (B) to show independent contributions of the lung function indices 
after adjustment for covariates. The AUC values were not statistically significantly different from each other. AUC, area under 
the curve; FEV1, forced expiratory volume in 1 s; FRC, functional residual capacity; FVC, forced vital capacity; RV, residual 
volume; TLC, total lung capacity.
Table 6 Association of maximum exercise capacity and 
SHS exposure
Variable
VO2max (mL/min)
r2=0.39
PE±SEM P values
Cabin SHS exposure (years) −7±4 0.040
Childhood home SHS exposure −6±63 0.930
Adult home SHS exposure −16±66 0.805
Non-airline occupational SHS exposure 91±60 0.134
Other SHS exposure* −29±67 0.661
Age −10±4 0.008
Height 9±6 0.134
Weight 1±4 0.722
Sex −448±144 0.002
The association of maximum exercise capacity (VO2max) 
with SHS was estimated using the regression analyses with 
adjustment for age, sex, height and weight on the regression 
model: Work=β0+β1(age)+β2(height)+β3(weight)+β4(sex)+β5(cabin 
SHS)+β6(non-cabin SHS). SHS exposures were included as 
dichotomous variable except for cabin SHS exposure.
*Other SHS exposure was defined as non-aircraft cabin SHS 
exposure outside the work or home environment such as in 
recreational public places. n=127. Significant p-values are 
shown in bold.  
PE±SEM, parameter estimate±SEM; r2, model fit; SHS, 
secondhand tobacco smoke; VO2max, maximum oxygen 
uptake. 
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maximum exercise capacity was not mediated by airflow 
obstruction as measured by spirometric airflow indices, and 
suggests that air trapping may reflect additional pathophys-
iology beyond what is measured by the airflow indices of 
small airways. Evidence supporting this hypothesis includes 
other studies in patients with overt obstruction, which have 
shown persistence of air trapping for days to weeks even 
after improvement in airflow obstruction by bronchodi-
lator therapy.7–9 Interestingly, a recent cohort study showed 
that the areas with gas trapping on CT imaging of patients 
with COPD indeed proceed to become emphysematous on 
follow-up CT imaging.37 Overall, it appears that the patho-
physiology of air trapping may be more complicated than 
previously thought.
In recent years, CT imaging has been used extensively 
to characterise patients with COPD and identify radio-
graphic characteristics that could help define functional 
phenotypes. Some of these measures include presence 
of emphysema, airway wall thickening and ‘gas trap-
ping’. Additionally, various methods have been proposed 
for optimal quantification of these radiographic attri-
butes.24–28 38 A few of these studies have shown gas trapping 
to be associated with poor respiratory outcomes.34 39 In our 
study, we used a method validated by Matsuoka et al40 to 
measure gas trapping via calculation of LAAexp −860 to  −950 in 
subjects with preserved spirometry. Remarkably, even in the 
small number of subjects examined in our radiographic 
subset, LAAexp −860 to −950 was associated with lower maximum 
exercise capacity. Our findings are consistent with another 
recent report about the association of gas trapping on CT 
imaging and respiratory symptoms in a cohort of smokers 
without spirometric COPD.41
Our study has limitations that should be kept in view. 
The cohort studied had only modest past direct smoking 
but experienced substantial SHS exposure. The American 
Thoracic Society statement on COPD considers SHS expo-
sure to be a possible, but not definite, cause of COPD.42 
Since that statement, however, further evidence has 
emerged supporting a contribution of SHS to development 
of COPD as well as to obstructive-type lung disease which do 
not meet the current definition of COPD.20 43 The weight 
of new evidence suggests that the disease caused by expo-
sure to SHS, while it may not be spirometrically defined 
as COPD, is indeed similar to the lung disease of those 
smokers without GOLD-defined COPD.17 18 44 Another 
potential limitation is that to assess the presence of respi-
ratory symptoms, we used mMRC and a similar question-
naire that additionally asked about coughing,19 and found 
a significant association of RV/TLC only with the latter. 
However, the direction of association of RV/TLC with 
symptoms measured by mMRC, although not significant, 
was consistent with our hypothesis.
In conclusion, we found that in a cohort at risk for COPD 
due to prolonged occupational exposure to SHS but 
without spirometric COPD, lung volumes representing air 
trapping (RV/TLC) had a wide distribution across incre-
ments of airflow indices. Higher RV/TLC, even within 
normal range, identified a subgroup with more prevalent 
respiratory symptoms and lower exercise capacity. Many of 
those without abnormal RV/TLC and frank air trapping 
had or developed EFL with exercise, which was associated 
with respiratory symptoms and exercise capacity. Our find-
ings, along with other literature, suggest that lung volumes 
representing air trapping could be used for prognostica-
tion in populations with preserved spirometry who are at 
risk for COPD due to any cause such as direct smoking or 
air pollution.
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